# Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease

Study · id `cardio:ct-nct06710210` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06710210](<https://clinicaltrials.gov/study/NCT06710210>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06710210

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT06710210. Randomized; single masking; primary purpose treatment. Start 2026-04-01 (actual); primary completion 2028-04-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT06710210, source copy `cardio:ctgov-nct06710210-2026-09-02`, retrieved 2026-10-26)
- Started: 2026-04-01 (actual) (ClinicalTrials.gov record NCT06710210, source copy `cardio:ctgov-nct06710210-2026-09-02`, retrieved 2026-10-26)
- Primary completion: 2028-04-01 (anticipated) (ClinicalTrials.gov record NCT06710210, source copy `cardio:ctgov-nct06710210-2026-09-02`, retrieved 2026-10-26)
- Completion: 2028-04-01 (anticipated) (ClinicalTrials.gov record NCT06710210, source copy `cardio:ctgov-nct06710210-2026-09-02`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT06710210, source copy `cardio:ctgov-nct06710210-2026-09-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06710210-2026-09-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease
- Acronym: BIOHYBRID
- Condition: Coronary Artery Disease
- Condition: Diffuse Coronary Artery Disease
- Condition: Percutaneous Coronary Intervention (PCI)
- Intervention (Device): PCI with a bioresorbable scaffold and drug-coated balloon(s)
- Intervention (Device): PCI with drug-eluting stent(s)
- Lead sponsor: University Hospital, Geneva
- Lead sponsor class: OTHER
- Collaborator: Clinical Trials Unit Bern (CTU)
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: University Hospital, Geneva (`cardio:org-university-hospital-geneva`)

## Provenance

Content hash: d4f0861b41093e4dc5af933008efb43dac87f11ad9df2bbeb35f2dc9b9ef0cd2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
